Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP160412 for Relief of Sunburn
NCT03332524Phase 2Terminated
- Sponsor
- Sephoris Pharmaceuticals
- Start
- Jan 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ibuprofen and chlorpheniramine in sunburn (3 arms), sponsored by Sephoris Pharmaceuticals. Primary endpoint: Self reported pain score on Pain Numeric Scale (NRS). Started Jan 2018; status: terminated.
02
Drugs
ibuprofenchlorpheniramine
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT03332524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03332524.